APVO   $4.79  -3.82% Market Closed

Aptevo Therapeutics Inc
Total Cash 8.07M
totalCashPerShare 0.856
EBITDA -25.52M
Total Debt 5.72M
quickRatio 1.488
currentRatio 1.768
Total Revenue
debtToEquity 128.277
Revenue/Share
ROA -0.74004996
ROE -2.43734
grossProfits
freeCashflow -16.01M
operatingCashflow -24.30M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 183.69K
forwardPE -0.044253856
floatShares 8.89M
sharesOutstanding 13.44M
sharesShort 154.73K
sharesShortPriorMonth 13.02K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.00%
heldPercentInstitutions 0.14%
Short Ratio help_outline 0.06%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 1.094
Price To Book help_outline 0.24
earningsQuarterlyGrowth
netIncomeToCommon -25.25M
trailingEps -35.64%
forwardEps -5.83%
enterpriseToEbitda -0.01
lastDividendValue
lastDividendDate
currentQuarterEstimate -3.35 3Q 2024
institutionsCount 19
lastUpdated Nov. 7, 2024, 2:30 a.m.